Alright, so you’ve heard of Ozempic, right? The “magic” weight loss drug that’s everywhere—TikTok, the news, probably y ...

Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher Monday. The company is set to join to the S&P SmallCap 600 this ...

The FDA has resolved Eli Lilly's tirzepatide shortage, but localized supply issues persist. Meanwhile, Hims & Hers Health's ...

As a player in the growing telehealth sector, Hims & Hers Health ($HIMS) has grown significantly, driving its stock up over ...

Stock prices used were end-of-day prices of Oct. 3, 2024. The video was published on Oct. 3, 2024. Before you buy stock in Hims & Hers Health, consider this: The Motley Fool Stock Advisor analyst ...

Board directors of Mars Area School District unanimously agreed to join a class action lawsuit against Eli Lilly and Company ...

Generic drugs gave Americans access to effective, cheap prescription medications. It’s saved them trillions of dollars over ...

As of October 3 at 11:50 AM EDT. Market Open.

The bold move has been accompanied by a full-page ad in the Wall Street Journal explaining its reasoning, and claiming that the prices of GLP-1 drugs for weight loss are five times too high and ...

The Centers for Medicare & Medicaid Services Oct. 9 released a request for information and a sample list of prescription ...